血清miR-320、HMGB1对急性呼吸窘迫综合征患者临床预后的影响

摘要/Abstract

摘要： 目的探讨血清miR-320、高迁移率族蛋白B1（HMGB1）对急性呼吸窘迫综合征（ARDS）患者临床预后的影响。方法选择2019年3月~2021年3月河南科技大学第一附属医院收治的86例ARDS患者作为研究对象,患者均在本院接受规范化治疗,记录患者28d内病死及存活情况作为预后观察指标,将病死患者纳入预后不良组,将存活患者纳入预后良好组;所有患者入院时均接受血清miR-320、HMGB1检测,询问并记录患者初始状况资料,分析血清miR-320、HMGB1水平对ARDS患者临床预后的影响。结果 86例ARDS患者经治疗,28d病死28例（32.56%）,存活58例（67.44%）;预后不良组中性粒细胞百分比、miR-320、HMGB1水平高于预后良好组,差异有统计学意义（P<0.05）;COX回归分析结果显示,血清miR-320、HMGB1过表达是ARDS患者预后不良的影响因素（P<0.05）。结论血清miR-320、HMGB1过表达对ARDS患者预后不良存在一定影响。

关键词: 急性呼吸窘迫综合征, 微核糖核酸-320, 高迁移率族蛋白B1, 预后

Abstract: Objective To investigate the effects of serum miR-320 and high mobility group protein B1 (HMGB1) on the clinical prognosis of patients with acute respiratory distress syndrome (ARDS). Methods Eighty-six patients with ARDS treated in the First Affiliated Hospital of Henan University of Science and Technology from March 2019 to March 2021 were selected as the research subjects. All patients received standardized treatment in our hospital. The death and survival of patients within 28 days were recorded as prognostic indicators. The patients who died were included in the poor prognosis group, and the patients who survived were included in the good prognosis group. All patients were tested for serum miR-320 and HMGB1 at admission. The initial status data of patients were inquired and recorded, and the effects of serum miR-320 and HMGB1 levels on the clinical prognosis of patients with ARDS were analyzed. Results In 86 patients with ARDS after treatment, 28 cases (32.56%) died and 58 cases (67.44%) survived in 28 days. The percentage of neutrophils, the levels of miR-320 and HMGB1 in the poor prognosis group were higher than those in the good prognosis group, the differences were statistically significant (P<0.05). The results of COX regression analysis showed that the overexpression of serum miR-320 and HMGB1 were the influencing factors of poor prognosis in patients with ARDS (P<0.05). Conclusion The overexpression of serum miR-320 and HMGB1 has a certain impact on the poor prognosis of patients with ARDS.

Key words: acute respiratory distress syndrome, microRNA-320, high mobility group protein B1, prognosis

中图分类号:

R563

平京娜. 血清miR-320、HMGB1对急性呼吸窘迫综合征患者临床预后的影响[J]. 承德医学院学报, 2022, 39(3): 212-215.

PING Jing-na. Effects of Serum miR-320 and HMGB1 on Clinical Prognosis of Patients with Acute Respiratory Distress Syndrome[J]. Journal of Chengde Medical University, 2022, 39(3): 212-215.

[1]	严汀华, 谢雪华, 江金华, 吴炜. NLR在乙肝相关慢加急性肝衰竭诊断及预后预测价值[J]. 承德医学院学报, 2021, 38(5): 379-382.
[2]	张海红. 专职化管理小组模式在急性呼吸窘迫综合征患儿中的应用[J]. 承德医学院学报, 2021, 38(4): 327-329.
[3]	曾宪任. 优化急诊护理流程对急性心肌梗死患者救治效果的分析[J]. 承德医学院学报, 2021, 38(4): 317-319.
[4]	李雪峰, 王清芳, 冯玉凤. Lp-PLA2、Annexin A2与溶栓后急性缺血性脑卒中患者预后的相关性[J]. 承德医学院学报, 2021, 38(4): 301-305.
[5]	王建新. 小承气汤加减鼻饲辅助治疗ARDS患者的效果观察[J]. 承德医学院学报, 2021, 38(3): 217-219.
[6]	王丹丹, 巨士文. 子宫内膜异位症患者VEGF、MMP-9、tPA水平与预后关系分析[J]. 承德医学院学报, 2021, 38(3): 191-194.
[7]	卓艳霞, 孙明昌, 张永卓. 儿童急性淋巴细胞白血病中miR-326的表达及临床意义[J]. 承德医学院学报, 2021, 38(1): 9-12.
[8]	王丽娟, 刘燕. miR-708在儿童急性淋巴细胞白血病中的诊断及预后[J]. 承德医学院学报, 2021, 38(1): 1-5.
[9]	戴允楠, 殷玉明, 李青山. 血常规参数与妇科恶性肿瘤预后关系的研究进展[J]. 承德医学院学报, 2020, 37(6): 512-515.
[10]	何孝敏. 原发性肝癌患者TSGF、GP73水平与预后关系的研究[J]. 承德医学院学报, 2020, 37(5): 374-377.
[11]	张莉. 急性ST段抬高型心肌梗死患者可溶性致癌抑制因子2水平与预后的相关性[J]. 承德医学院学报, 2020, 37(4): 296-298.
[12]	邝静. 俯卧位通气护理对严重创伤后ARDS患者预后的影响[J]. 承德医学院学报, 2020, 37(1): 52-53.
[13]	薛晶雯, 王又君, 郭静, 张金洋, 吕喜英. 预后营养指数评估小细胞肺癌患者预后的临床价值[J]. 承德医学院学报, 2019, 36(5): 393-397.
[14]	盛欢欢. 彩超引导下射频消融术治疗甲状腺良性结节的效果及预后观察[J]. 承德医学院学报, 2019, 36(5): 371-374.
[15]	乔方. 降钙素原、血小板计数评估多发性创伤患者预后的价值[J]. 承德医学院学报, 2018, 35(6): 478-480.

血清miR-320、HMGB1对急性呼吸窘迫综合征患者临床预后的影响

Effects of Serum miR-320 and HMGB1 on Clinical Prognosis of Patients with Acute Respiratory Distress Syndrome

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价